Position in AVR
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$963,881
+$635,416 QoQ
Shares Held
97,856
+65.3% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#48
of 135 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 17%
Shared 0%
None 83%
Common Shares in AVR Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,271,214,892 across 85 Medical Devices names. AVR ranks #42 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
2,820,543 | $255,936,071 | |
| 2 | SYK |
Stryker Corp
|
616,745 | $194,175,995 | |
| 3 | MDT |
Medtronic plc
|
2,213,044 | $173,126,432 | |
| 4 | BSX |
Boston Scientific Corp
|
2,641,843 | $112,753,859 | |
| 5 | EW |
Edwards Lifesciences Corp
|
1,096,770 | $99,213,814 | |
| 6 | DXCM |
Dexcom Inc
|
768,165 | $51,735,912 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
755,006 | $48,327,934 | |
| 8 | STE |
STERIS plc
|
217,541 | $45,807,608 |
All Filings in AVR
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $963,881 | 97,856 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $328,465 | 59,183 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $187,833 | 37,642 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $149,395 | 33,199 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $96,284 | 25,405 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $44,564 | 12,243 | Shares | Sole | 2025-05-29 | |
| No filing history on record for this holder in this stock. | ||||||